September 28, 2016
3 min watch
Save

VIDEO: A new endovascular approach to arteriovenous fistula creation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LAS VEGAS — In this video exclusive, Tony Das, MD, an interventional cardiologist at Walnut Hill Medical Center, Dallas, discusses use of a novel endovascular device to create arteriovenous fistulas and new data from the NEAT trial on this endovascular approach.

Das highlighted results of a comparison between surgical arteriovenous (AV) fistula creation and a new endovascular approach using the everlinQ procedure (TVA Medical) presented at VIVA 16. The catheter-based device uses radiofrequency energy in a minimally invasive method of endovascular fistula creation. Creation and use of an AV fistula can benefit patients with late-stage kidney disease who need hemodialysis access.

“The dialysis population is growing dramatically,” Das said. “Novel techniques that have a potential for successful development of AV grafts and fistulas that would be able to be used quicker than the traditional surgical technique may be of significant utility.”

These data suggest “a complete change of the paradigm of creating AV fistulas,” according to Das. “This is something we’ll be following very closely in [the] endovascular field.”